Latest Regulatory Approval News

Terramin's December 2024 quarterly report reveals major progress at its Tala Hamza Zinc Project with land acquisition and a $336 million EPC contract, while the Bird in Hand Gold Project faces a legal hurdle after the Supreme Court dismissed its mining lease application.

Zelira Therapeutics has received a fourth funding tranche, bringing total investment to US$3.25 million to support FDA clinical trials of its HOPE® 1 cannabinoid medicine targeting irritability in autism spectrum disorder and Phelan-McDermid Syndrome.

Westar Resources reports exceptional gold and silver assay results from its Mindoolah Mining Centre, setting the stage for imminent drilling programs in early 2025. The company maintains a strong cash position while strategically focusing on high-potential projects.

Argosy Minerals has reported significant progress on its flagship Rincon Lithium Project, including an upgraded mineral resource estimate and advancing engineering and feasibility studies toward a 12,000tpa lithium carbonate operation.

CZR Resources updates investors on the extended FIRB approval timeline for its Robe Mesa Iron Ore Project sale, highlighting amended transaction terms that allow termination before the new February deadline.

Auswide Bank has secured Treasurer approval for MyState Bank’s acquisition via a scheme of arrangement, setting the stage for a pivotal shareholder vote in early February.

360 Capital Group has announced a fully franked dividend of AUD 0.02 per security for the six months ending December 31, 2024, payable on January 24, 2025. This update confirms the payment details and clarifies the distribution source.

Altamin Limited has completed the acquisition of Appian Italy’s 29.85% stake in Vedra Metals, gaining 100% ownership of the Gorno Project and positioning itself for streamlined development or sale.

Delta Lithium reports promising drilling outcomes at its fully permitted Mt Ida Gold Project, confirming resource growth potential and endorsing a standalone development strategy.

Clarity Pharmaceuticals has secured a second FDA Fast Track Designation for its 64Cu-SAR-bisPSMA diagnostic agent, aiming to revolutionize prostate cancer imaging and speed regulatory approval.

Amcor plc has taken a pivotal step in its proposed merger with Berry Global by filing the definitive joint proxy statement with the SEC, setting the stage for shareholder votes in February. Integration planning is well underway as both companies prepare to unite their packaging expertise.

Poseidon Nickel has taken a strategic leap with a proposed merger with Horizon Minerals, aiming to combine resources and processing infrastructure. Concurrently, exploration programs at Black Swan and Lake Johnston have unveiled significant gold and lithium anomalies, underscoring the potential of the combined entity.